Insider Trading disclosures for Globe Life Inc

The latest disclosure was made by Michael Shane Henrie in Globe Life Inc where a trade of 2,750 Common Stock done at an average price of $126.4 was reported to US exchanges on March 19, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Michael Shane Henrie	SVP & Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 126.41 per share.	19 Mar 2025	2,750	3,040 (0%)	0%	126.4	347,641	Common Stock
Michael Shane Henrie	SVP & Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	19 Mar 2025	2,750	3,250	-		-	Employee Stock Option (Right to Buy)
Michael Shane Henrie	SVP & Chief Accounting Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 103.23 per share.	19 Mar 2025	2,750	5,790 (0%)	0%	103.2	283,883	Common Stock
Robert Edward Hensley	EVP & Chief Investment Officer	Sale of securities on an exchange or to another person at price $ 124.81 per share.	04 Mar 2025	1,610	10,193 (0%)	0%	124.8	200,952	Common Stock
Philip M. Jacobs	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	1,183	1,183 (0%)	0%		0	Common Stock
Matthew J. Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	1,183	1,183 (0%)	0%		0	Common Stock
Michael Shane Henrie	SVP & Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2025	1,220	3,040 (0%)	0%		0	Common Stock
Michael Shane Henrie	SVP & Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2025	3,800	3,800	-		-	Employee Stock Option (Right to Buy)
Christopher Kyle Tyler	EVP and Chief Info Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2025	1,125	5,245 (0%)	0%		0	Common Stock
Dolores L. Skarjune	EVP and Chief Admin. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2025	11,200	11,200	-		-	Employee Stock Option (right to buy)
Christopher Kyle Tyler	EVP and Chief Info Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2025	10,600	10,600	-		-	Employee Stock Option (Right to Buy)
Dolores L. Skarjune	EVP and Chief Admin. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2025	1,205	8,191 (0%)	0%		0	Common Stock
Thomas Peter Kalmbach	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	16,700	16,700	-		-	Employee Stock Option (Right to Buy)
Rebecca E. Zorn	EVP & Chief Talent Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	1,746	12,669 (0%)	0%	121.9	212,890	Common Stock
Rebecca E. Zorn	EVP & Chief Talent Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	4,307	14,415 (0%)	0%		0	Common Stock
Rebecca E. Zorn	EVP & Chief Talent Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	8,600	8,600	-		-	Employee Stock Option (Right to Buy)
Rebecca E. Zorn	EVP & Chief Talent Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	980	13,649 (0%)	0%		0	Common Stock
Jennifer A. Haworth	EVP & Chief Marketing Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	1,907	16,424 (0%)	0%	121.9	232,521	Common Stock
Jennifer A. Haworth	EVP & Chief Marketing Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	9,300	9	-		-	Employee Stock Option (Right to Buy)
Jennifer A. Haworth	EVP & Chief Marketing Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,055	17,479 (0%)	0%		0	Common Stock
Jennifer A. Haworth	EVP & Chief Marketing Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	4,846	18,331 (0%)	0%		0	Common Stock
Thomas Peter Kalmbach	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,780	24,596 (0%)	0%		0	Common Stock
Thomas Peter Kalmbach	EVP & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	3,004	22,816 (0%)	0%	121.9	366,278	Common Stock
Thomas Peter Kalmbach	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	7,537	25,820 (0%)	0%		0	Common Stock
Robert Edward Hensley	EVP & Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	12,400	12,400	-		-	Employee Stock Option (Right to Buy)
Robert Edward Hensley	EVP & Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	5,384	12,674 (0%)	0%		0	Common Stock
Robert Edward Hensley	EVP & Chief Investment Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	2,161	10,513 (0%)	0%	121.9	263,491	Common Stock
Robert Edward Hensley	EVP & Chief Investment Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,290	11,803 (0%)	0%		0	Common Stock
James Matthew Darden	Director, Co-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	3,686	49,842 (0%)	0%		0	Common Stock
Frank M. Svoboda	Director, Co-Chairman & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	4,662	26,131 (0%)	0%	121.9	568,438	Common Stock
Frank M. Svoboda	Director, Co-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	50,471	50,471	-		-	Employee Stock Option (Right to Buy)
Frank M. Svoboda	Director, Co-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	3,686	29,817 (0%)	0%		0	Common Stock
Frank M. Svoboda	Director, Co-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	11,845	30,793 (0%)	0%		0	Common Stock
Majors Clay Michael	EVP - Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	12,800	12,800	-		-	Employee Stock Option (Right to Buy)
Majors Clay Michael	EVP - Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,385	47,066 (0%)	0%		0	Common Stock
Majors Clay Michael	EVP - Chief Strategy Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	3,007	45,681 (0%)	0%	121.9	366,644	Common Stock
Majors Clay Michael	EVP - Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	7,537	48,688 (0%)	0%		0	Common Stock
R. Brian Mitchell	EVP, General Counsel and CRO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	2,755	6,764 (0%)	0%	121.9	335,917	Common Stock
R. Brian Mitchell	EVP, General Counsel and CRO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	12,200	12,200	-		-	Employee Stock Option (Right to Buy)
R. Brian Mitchell	EVP, General Counsel and CRO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	1,310	8,074 (0%)	0%		0	Common Stock
R. Brian Mitchell	EVP, General Counsel and CRO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	6,999	9,519 (0%)	0%		0	Common Stock
James Matthew Darden	Director, Co-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	11,845	50,818 (0%)	0%		0	Common Stock
James Matthew Darden	Director, Co-Chairman & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.93 per share.	26 Feb 2025	4,662	46,156 (0%)	0%	121.9	568,438	Common Stock
James Matthew Darden	Director, Co-Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Feb 2025	50,471	50,471	-		-	Employee Stock Option (Right to Buy)
Frank M. Svoboda	Director, Co-Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	10,750	0	-		-	Employee Stock Option (Right to Buy)
Frank M. Svoboda	Director, Co-Chairman & CEO	Sale of securities on an exchange or to another person at price $ 122.31 per share.	13 Feb 2025	11,000	18,948 (0%)	0%	122.3	1,345,379	Common Stock
Frank M. Svoboda	Director, Co-Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.60 per share.	13 Feb 2025	10,750	29,698 (0%)	0%	87.6	941,700	Common Stock
Frank M. Svoboda	Director, Co-Chairman & CEO	Sale of securities on an exchange or to another person at price $ 122.37 per share.	13 Feb 2025	8,340	21,358 (0%)	0%	122.4	1,020,567	Common Stock
Frank M. Svoboda	Director, Co-Chairman & CEO	Sale of securities on an exchange or to another person at price $ 123.14 per share.	13 Feb 2025	2,410	18,948 (0%)	0%	123.1	296,763	Common Stock
Frank M. Svoboda	Director, Co-Chairman & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Feb 2025	11,000	10,750	-		-	Employee Stock Option (Right to Buy)

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

71.97% Gain from 52W Low

Insider Trading disclosures for Globe Life Inc

The latest disclosure was made by Michael Shane Henrie in Globe Life Inc where a trade of 2,750 Common Stock done at an average price of $126.4 was reported to US exchanges on March 19, 2025.

Screeners based on Insider Trading and SAST parameters